Lipoprotein subclass metabolism in nonalcoholic steatohepatitis

J Lipid Res. 2014 Dec;55(12):2676-84. doi: 10.1194/jlr.P054387. Epub 2014 Oct 24.

Abstract

Nonalcoholic steatohepatitis (NASH) is associated with increased synthesis of triglycerides and cholesterol coupled with increased VLDL synthesis in the liver. In addition, increased cholesterol content in the liver associates with NASH. Here we study the association of lipoprotein subclass metabolism with NASH. To this aim, liver biopsies from 116 morbidly obese individuals [age 47.3 ± 8.7 (mean ± SD) years, BMI 45.1 ± 6.1 kg/m², 39 men and 77 women] were used for histological assessment. Proton NMR spectroscopy was used to measure lipid concentrations of 14 lipoprotein subclasses in native serum samples at baseline and after obesity surgery. We observed that total lipid concentration of VLDL and LDL subclasses, but not HDL subclasses, associated with NASH [false discovery rate (FDR) < 0.1]. More specifically, total lipid and cholesterol concentration of VLDL and LDL subclasses associated with inflammation, fibrosis, and cell injury (FDR < 0.1), independent of steatosis. Cholesterol concentration of all VLDL subclasses also correlated with total and free cholesterol content in the liver. All NASH-related changes in lipoprotein subclasses were reversed by obesity surgery. High total lipid and cholesterol concentration of serum VLDL and LDL subclasses are linked to cholesterol accumulation in the liver and to liver cell injury in NASH.

Keywords: high density lipoprotein; lipids; lipoproteins/metabolism; liver; low density lipoprotein; nuclear magnetic resonance; obesity; obesity surgery; very low density lipoprotein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Body Mass Index
  • Cholesterol / blood
  • Cholesterol / metabolism
  • Cholesterol, VLDL / blood
  • Cholesterol, VLDL / metabolism
  • Female
  • Finland
  • Gastric Bypass
  • Hospitals, University
  • Humans
  • Hyperlipidemias / etiology
  • Hyperlipidemias / prevention & control
  • Lipids / analysis
  • Lipids / blood
  • Lipoproteins, HDL / blood
  • Lipoproteins, HDL / metabolism
  • Lipoproteins, LDL / blood
  • Lipoproteins, LDL / metabolism*
  • Lipoproteins, VLDL / blood
  • Lipoproteins, VLDL / metabolism*
  • Liver / immunology
  • Liver / metabolism*
  • Liver / pathology
  • Liver Cirrhosis / etiology
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / etiology
  • Non-alcoholic Fatty Liver Disease / immunology
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Obesity, Morbid / physiopathology*
  • Obesity, Morbid / surgery

Substances

  • Cholesterol, VLDL
  • Lipids
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Lipoproteins, VLDL
  • Cholesterol